Multimodal integration of longitudinal noninvasive diagnostics for survival prediction in immunotherapy using deep learning.
Immunotherapies have revolutionized the landscape of cancer treatments. However, our understanding of response patterns in advanced cancers treated with immunotherapy remains limited. By leveraging routinely collected noninvasive longitudinal and multimodal data with artificial intelligence, we could unlock the potential to transform immunotherapy for cancer patients, paving the way for personalized treatment approaches.
Author(s): Yeghaian, Melda, Bodalal, Zuhir, van den Broek, Daan, Haanen, John B A G, Beets-Tan, Regina G H, Trebeschi, Stefano, van Gerven, Marcel A J
DOI: 10.1093/jamia/ocaf074